Stake Purchase • Life Science

Bain Capital Private Equity Invests In Emcure Pharmaceuticals

On December 19, 2013, private equity firm Bain Capital Private Equity invested in life science company Emcure Pharmaceuticals from The Blackstone Group

Investment Context
  • This is Bain Capital Private Equity’s 5th transaction in the Life Science sector.
  • This is Bain Capital Private Equity’s 4th transaction in India.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary

Date December 19, 2013
Target Emcure Pharmaceuticals
Sector Life Science
Investor(s) Bain Capital Private Equity
Sellers(s) The Blackstone Group
Deal Type Stake Purchase

Target Company

Emcure Pharmaceuticals

Pune, India
Emcure Pharmaceuticals is a mid-sized pharmaceutical business. The company's activities include research & development, manufacturing of APIs, branded formulations and biotech products, and marketing of these products in India and international markets. Emcure Pharmaceuticals was founded in 1981 and is based in Pune, India.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Bain Capital Private Equity

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1984
PE ASSETS 44.2B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Bain Capital Private Equity (BCPE), is the private equity investment arm of alternative asset management firm, Bain Capital. BCPE targets leveraged buyout and growth capital transactions in a wide variety of industries including information technology, communications, media, healthcare, industrial/manufacturing, retail/consumer, and financial services. Bain Capital is based in Boston with additional offices in New York, London, Mumbai, Hong Kong, Shanghai, Tokyo, and Munich.


Deal Context for Investor #
Overall 115 of 253
Sector: Life Science 5 of 13
Type: Stake Purchase 10 of 22
Country: India 4 of 8
Year: 2013 15 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-11 MEI Conlux Holdings

Malvern, Pennsylvania, United States

MEI is a provider of coin recognition technology for vending machines.

Sell $804M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-23 Accelecare Wound Centers

Bellevue, Washington, United States

Accelecare Wound Centers, Inc. is a wound care and disease management company focused on providing full service wound management solutions to hospitals and related health care organizations across the United States. Accelecare Wound Centers was formed in 2007 and is based in Bellevue, Washington.

Sell $70M

Seller Profile 1

SELLER

The Blackstone Group

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1987
PE ASSETS 394.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

The Blackstone Group is a global alternative investment management firm. The Firm's investment activities span real estate, secondary investments, hedge funds, credit, infrastructure, and private equity. Blackstone's private equity group targets opportunities globally including buyout acquisitions of established companies, development projects, growth equity financings, and industry consolidations. Sectors of interest include automotive, healthcare, chemicals, industrial, commercial property, lodging, communications, media/publishing, consumer & retail, packaging, consumer products, pharmaceuticals, energy, technology, entertainment, telecommunications, financial services, theme parks, food & beverage, and transportation. Blackstone's private equity real estate group looks for opportunities across North/South America, Asia, Australia/New Zealand, and Europe. The real estate group will consider both equity and debt investments. Areas of interest include healthcare, hotel, industrial, office, residential, and retail. The Blackstone Group was formed in 1987 and is based in New York, New York.


Deal Context for Seller #
Overall 83 of 195
Sector: Life Science 3 of 5
Type: Stake Purchase 4 of 10
Country: India 2 of 13
Year: 2013 13 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-13 Cheniere Energy

Houston, Texas, United States

Cheniere Energy is an energy company that primarily engages in the development, construction, ownership, and operation of onshore liquefied natural gas (LNG) receiving terminals and natural gas pipelines along the Gulf Coast of the United States. Cheniere Energy was founded in 1983 and is based in Houston, Texas.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-01 Vine Energy

Plano, Texas, United States

Vine Energy is an energy company focused on the development of natural gas properties in the stacked Haynesville and Mid-Bossier shale plays in the Haynesville Basin of Northwest Louisiana. Vine Energy was founded in 2014 and is based in Plano, Texas.

Buy -

Explore Related M&A Activity